Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorma Isola

Showing results (11-20 of 145) with videos related to

Pageof 15
Sort By:
Cancer Letters|April 5, 2011
Trastuzumab-DM1 is highly effective in preclinical models of HER2-positive gastric cancerMark Barok, Minna Tanner, Katri Köninki, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 26, 2018
Fluoro-Chromogenic Labelling for Detection of MCM2 to Assess Proliferation Activity in HER2-amplified Breast CarcinomasSatu Luhtala, Teppo Haapaniemi, Synnöve Staff, et al.
BMJ (Clinical Research Ed.)|January 4, 2003
A web-based system for individualised survival estimation in breast cancerJohan Lundin, Mikael Lundin, Jorma Isola, et al.
Histopathology|February 3, 2012
ImmunoMembrane: a publicly available web application for digital image analysis of HER2 immunohistochemistryVilppu J Tuominen, Teemu T Tolonen, Jorma Isola
Breast Cancer Research : BCR|June 23, 2009
HER-2 positive breast cancer: decreasing proportion but stable incidence in Finnish population from 1982 to 2005Katri Köninki, Minna Tanner, Anssi Auvinen, et al.
Oncology Reports|January 1, 2010
Aurora-A gene is frequently amplified in basal-like breast cancerSynnöve Staff, Jorma Isola, Mervi Jumppanen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 27, 2016
Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancerSatu Luhtala, Synnöve Staff, Minna Tanner, et al.
Studies in Health Technology and Informatics|December 11, 2003
Evaluation of a web-based system for survival estimation in breast cancerJohan Lundin, Mikael Lundin, Jorma Isola, et al.
Breast Cancer Research : BCR|April 23, 2011
Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivoMark Barok, Minna Tanner, Katri Köninki, et al.
Studies in Health Technology and Informatics|September 14, 2004
Validation of a Web-based prognostic system for breast cancerJohan Lundin, Mikael Lundin, Jorma Isola, et al.
Pageof 15

Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
Cancer Letters|April 5, 2011
Trastuzumab-DM1 is highly effective in preclinical models of HER2-positive gastric cancerMark Barok, Minna Tanner, Katri Köninki, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 26, 2018
Fluoro-Chromogenic Labelling for Detection of MCM2 to Assess Proliferation Activity in HER2-amplified Breast CarcinomasSatu Luhtala, Teppo Haapaniemi, Synnöve Staff, et al.
BMJ (Clinical Research Ed.)|January 4, 2003
A web-based system for individualised survival estimation in breast cancerJohan Lundin, Mikael Lundin, Jorma Isola, et al.
Histopathology|February 3, 2012
ImmunoMembrane: a publicly available web application for digital image analysis of HER2 immunohistochemistryVilppu J Tuominen, Teemu T Tolonen, Jorma Isola
Breast Cancer Research : BCR|June 23, 2009
HER-2 positive breast cancer: decreasing proportion but stable incidence in Finnish population from 1982 to 2005Katri Köninki, Minna Tanner, Anssi Auvinen, et al.
Oncology Reports|January 1, 2010
Aurora-A gene is frequently amplified in basal-like breast cancerSynnöve Staff, Jorma Isola, Mervi Jumppanen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 27, 2016
Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancerSatu Luhtala, Synnöve Staff, Minna Tanner, et al.
Studies in Health Technology and Informatics|December 11, 2003
Evaluation of a web-based system for survival estimation in breast cancerJohan Lundin, Mikael Lundin, Jorma Isola, et al.
Breast Cancer Research : BCR|April 23, 2011
Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivoMark Barok, Minna Tanner, Katri Köninki, et al.
Studies in Health Technology and Informatics|September 14, 2004
Validation of a Web-based prognostic system for breast cancerJohan Lundin, Mikael Lundin, Jorma Isola, et al.
Pageof 15